← Back to Search

Other

FS with ZOE Materials for Toothache

Q: What is the total participant count for this research endeavor?

Indeed, according to clinicaltrials.gov, this research endeavour remains recruiting participants since it was first advertised on February 2nd 2023 and last modified on June 6th of the same year. 150 patients are necessary from a single location for successful completion of the investigation.

Q: Does the research encompass individuals aged 60 or older?

Eligibility for this trial is limited to children between the ages of 3 and 7. Additionally, there are 11 studies available for those younger than 18 years old, as well as 8 trials designed specifically for elderly participants over 65.

Q: Are new participants still welcomed to join this experiment?

Clinicaltrials.gov confirms that this trial is open for enrolment, having been initially posted on February 2nd 2023 and last amended on the 6th of the same month.

Q: What criteria must I satisfy to partake in this clinical investigation?

This medical trial seeks 150 participants aged 3-7 years old who are suffering from a toothache. Those selected must have carious teeth with reversible pulpitis and no more than one third of the roots undergoing physiological resorption, as well as being restorable by stainless steel crowns.

Phase < 1

Recruiting

Led By Jayakumar Jayaraman, BDS MDS PhD

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 36 months

Awards & highlights

Study Summary

This trial compares the effectiveness of two base materials (containing eugenol & without eugenol) used in primary molar pulpotomies to determine which one is more successful.

Who is the study for?

This trial is for children aged 3 to 7 with toothache due to reversible pulpitis in primary molars, which are not overly resorbed and can be restored with a crown. Kids mustn't have spontaneous pain, signs of advanced pulp issues, excessive bleeding, swelling or fistulae, nor any root resorption seen on x-rays.Check my eligibility

What is being tested?

The study compares two base materials used in pulpotomies: one eugenol based (traditional ZOE) and one non-eugenol based (Cavit), both combined with Ferric Sulfate. It's designed to see if the non-eugenol option reduces failures like internal resorption.See study design

What are the potential side effects?

Potential side effects may include discomfort at the site of treatment, allergic reactions to materials used, or failure of the pulpotomy leading to further dental problems such as infection or tooth loss.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 36 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~36 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Clinical success rate

Radiographic success rate

Trial Design

2Treatment groups

Experimental Treatment

Group I: non-eugenol based ZOE and Ferric SulfateExperimental Treatment1 Intervention

non-eugenol based ZOE and Ferric Sulfate in primary molar pulpotomy procedures.

Group II: eugenol based zinc oxide and Ferric SulfateExperimental Treatment1 Intervention

eugenol based zinc oxide and Ferric Sulfate in primary molars pulpotomies procedures.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor

699 Previous Clinical Trials

22,884,895 Total Patients Enrolled

Jayakumar Jayaraman, BDS MDS PhDPrincipal InvestigatorVirginia Commonwealth University

Media Library

FS (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05557812 — Phase < 1

Toothache Research Study Groups: non-eugenol based ZOE and Ferric Sulfate, eugenol based zinc oxide and Ferric Sulfate

Toothache Clinical Trial 2023: FS Highlights & Side Effects. Trial Name: NCT05557812 — Phase < 1

FS (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05557812 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total participant count for this research endeavor?

"Indeed, according to clinicaltrials.gov, this research endeavour remains recruiting participants since it was first advertised on February 2nd 2023 and last modified on June 6th of the same year. 150 patients are necessary from a single location for successful completion of the investigation."

Answered by AI

Does the research encompass individuals aged 60 or older?

"Eligibility for this trial is limited to children between the ages of 3 and 7. Additionally, there are 11 studies available for those younger than 18 years old, as well as 8 trials designed specifically for elderly participants over 65."

Answered by AI

Are new participants still welcomed to join this experiment?

"Clinicaltrials.gov confirms that this trial is open for enrolment, having been initially posted on February 2nd 2023 and last amended on the 6th of the same month."

Answered by AI

What criteria must I satisfy to partake in this clinical investigation?

"This medical trial seeks 150 participants aged 3-7 years old who are suffering from a toothache. Those selected must have carious teeth with reversible pulpitis and no more than one third of the roots undergoing physiological resorption, as well as being restorable by stainless steel crowns."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Clinical Trial Comparing FS With ZOE and Non-eugenol Based Materials in Primary Teeth Pulpotomies

2023. "A Clinical Trial Comparing FS With ZOE and Non-eugenol Based Materials in Primary Teeth Pulpotomies". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05557812.